You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Class of Ultra-high-speed Optical Switches

    SBC: N.P. PHOTONICS, INC.            Topic: N/A

    N/A

    STTR Phase I 1999 Department of DefenseAir Force
  2. Nonlinear Reduced Order Modeling of Limit Cycle Oscillations of Aircraft Wiings

    SBC: ZONA TECHNOLOGY INC            Topic: N/A

    N/A

    STTR Phase I 1999 Department of DefenseAir Force
  3. N/A

    SBC: THREE RIVERS HOLDINGS, LLC            Topic: N/A

    N/A

    STTR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  4. BROAD SPECTRUM BETA-LACTAMASE INHIBITORS

    SBC: ALAMX, LLC            Topic: N/A

    DESCRIPTION (Adapted from the application): Penicillin-resistant bacteria pose a serious threat to human welfare. This project will generate new products designed to defeat resistant microorganisms. The most prevalent cause of bacterial resistance involves the destruction of the antibiotic with the enzyme B-lactamase. There are more than 255 known B-lactamases, whi ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  5. DEVELOPMENT OF THE GAME-CYCLE EXERCISE SYSTEM

    SBC: THREE RIVERS HOLDINGS, LLC            Topic: N/A

    DESCRIPTION (adapted from applicant's abstract): The activity level of people tends to decrease after a spinal cord injury. Studies have reported that daily wheelchair propulsion activity level of an individual with a spinal cord injury (SCI) is not sufficient to maintain or improve their cardiovascular fitness level. Sedentary individuals with paraplegia and tetraplegia ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  6. TISSUE SLICES FROM TRANSGENIC MICE-TOXICOLOGICAL TOOL

    SBC: VITRON, INC.            Topic: N/A

    DESCRIPTION (Adapted from the Investigator's Abstract): The main objective of this grant proposal is to use precision-cut tissues slices from genetically-modified mice as an in vitro system for rapid assessment for potential chemical toxicities. The Phase I goals are to develop two transgenic mice, one that has an aryl hydrocarbon receptor responsive p ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  7. Nonlinear Reduced Order Modeling of Limit Cycle Oscillations of Aircraft Wiings

    SBC: ZONA TECHNOLOGY INC            Topic: N/A

    The Zona technology/Duke University team process a challenging set of tasks to be accomplished in two years time that builds upon the very substantial progress already made in Phase I. Specifically, the 2D, Euler Euations CFD model (developed in Phase I)that uses a harmonic balance solution technique will be extended to include teh effects of viscosity (Navier-Stoke equations)and multiple structu ...

    STTR Phase I 2001 Department of DefenseAir Force
  8. Nonlinear Reduced Order Modeling of Limit Cycle Oscillations of Aircraft Wiings

    SBC: ZONA TECHNOLOGY INC            Topic: N/A

    The Zona technology/Duke University team process a challenging set of tasks to be accomplished in two years time that builds upon the very substantial progress already made in Phase I. Specifically, the 2D, Euler Euations CFD model (developed in Phase I)that uses a harmonic balance solution technique will be extended to include teh effects of viscosity (Navier-Stoke equations)and multiple structu ...

    STTR Phase II 2001 Department of DefenseAir Force
  9. NON-NATURAL AMINO ACIDS IN PEPTIDE DRUG DEVELOPMENT

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    Argolyn Bioscience Inc. is an early stage biotechnology company that creates novel peptide drugs and diagnostics with greatly improved intrinsic pharmaceutical properties through substitution of non-natural amino acid analogues for arginine (Arg) or lysine (Lys). In proof-of concept studies thus far, application of the Argolyn technology to peptides of therapeutic interest has resulted in dramatic ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. NOVEL NEUROTENSIN ANALOGS AS ANTISCHIZOPRENICS

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The brain peptide neurotensin (NT) and its active derivative NT [8-13] function as endogenous neuroleptics. Stable NT derivatives that cross the blood brain barrier therefore have significant potential for development as a new class of non-dopamineric antipsychotics expected not to display the adverse side effects associated with the dopaminergics. The best lit ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government